Table 1.
Sample Characteristics
| N | 304 |
| Age, y, M (SD) | 54.1 (4.0) |
| Race/ethnicity, n (%) | |
| Non-Hispanic white | 220 (72.4) |
| Black/othera | 84 (27.6) |
| Education, n (%) | |
| High school/some college/vocational | 129 (42.4) |
| College or higher | 175 (57.6) |
| Menopause stage, n (%) | |
| Perimenopausal | 49 (16.12) |
| Postmenopausal | 255 (83.88) |
| Parity, number of live births, median (IQR) | 2.0 (1.0–3.0) |
| BMI, M (SD) | 28.99 (6.76) |
| SBP, mm Hg, M (SD) | 119.85 (14.48) |
| DBP, mm Hg, M (SD) | 70.18 (9.11) |
| LDL-C, mg/dL, M (SD) | 130.42 (33.47) |
| HDL-C, mg/dL, M (SD) | 62.86 (14.84) |
| Triglycerides, mg/dL, median (IQR) | 96.00 (71.0–129.0) |
| HOMA, median (IQR) | 2.20 (1.68–3.18) |
| Medications, n (%) | |
| Blood pressure–lowering | 48 (15.8) |
| Antidiabetic | 10 (3.3) |
| Lipid-lowering | 39 (12.8) |
| β-Agonists | 14 (4.61) |
| Anxiety, median (IQR) | 32.10 (9.89) |
| Physical activity, leisure time, median (IQR) | 396 (0–1383) |
| Hot flashes, physiologically monitored number/24 h, median (IQR) | 6 (0–15) |
| E1, pg/mL, median (IQR) | 25.00 (16.50–37.00) |
| E2, pg/mL, median (IQR) | 4.95 (2.00–11.30) |
| T, ng/dL, median (IQR) | 25.55 (20.40–31.50) |
| SHBG, nmol/L, median (IQR) | 79.60 (50.00–122.10) |
| FT, median (IQR) | 0.33 (0.23–0.43) |
| FMD, %, M (SD) | 7.33 (3.91) |
| IMT, mm, M (SD) | 0.68 (0.11) |
| IAD, mm, M (SD) | 6.99 (0.60) |
| Plaque, n (%) | |
| None | 162 (53.6) |
| Any | 140 (46.4) |
Sample sizes for all variables: N = 304, except HOMA: n = 301; LDL-C: n = 302; E1: n = 302; T: n = 302; FT: n = 302; FMD: n = 271; IMT: n = 300; IAD: n = 302; and plaque: n = 302.
Abbreviations: DBP, diastolic blood pressure; IQR, interquartile range; M, mean; SBP, systolic blood pressure.
a
Black and other race/ethnicity n (%): black: 67 (22.04); Asian: 11 (3.62); Hispanic: 2 (0.66); and biracial: 4 (1.32).